1 |
Alanine
| 1件: Alanine Alanine | 2件: Alanine Alanine; L-alanine; | - | - | 4件: 6 6, 13, 298, 299 |
2 |
Ascorbic acid
| 1件: Ascorbic acid Ascorbic acid | 4件: Acidum ascorbicum Acidum ascorbicum; ASCORBIC ACID; Iron; Vitamin C; | - | - | 8件: 10 10, 97, 192, 206, 210, 211, 212, 298 |
3 |
Methionine
| 1件: Methionine Methionine | 3件: Butanoic acid Butanoic acid; L-methionine; Methionine; | - | - | 6件: 34 34, 84, 93, 229, 298, 300 |
4 |
Tyrosine
| 1件: Tyrosine Tyrosine | 4件: Alanine Alanine; L-Tyrosine; Propanoic acid; Tyrosine; | - | - | 5件: 6 6, 75, 86, 111, 298 |
5 |
Indomethacin
| 1件: Indomethacin Indomethacin | 2件: INDOMETACIN INDOMETACIN; Indomethacin; | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 3件: 225 225, 271, 298 |
6 |
Trimethoprim
| 1件: Trimethoprim Trimethoprim | 2件: Bactrim Bactrim; TRIMETHOPRIM; | - | - | 8件: 36 36, 44, 49, 60, 61, 85, 298, 299 |
7 |
Cholecalciferol
| 1件: Cholecalciferol Cholecalciferol | 5件: CHOLECALCIFEROL CHOLECALCIFEROL; COLECALCIFEROL; Multivitamin; Vitamin D; Vitamin D3; | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 24件: 6 6, 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 |
8 |
Acarbose
| 1件: Acarbose Acarbose | 1件: Acarbose Acarbose; | 5件: AMY2A AMY2A, AMY2B, GAA, GANC, MGAM 💬 | 7件: Carbohydrate digestion and absorption Carbohydrate digestion and absorption, Galactose metabolism, Lysosome, Metabolic pathways, Pancreatic secretion, Salivary secretion, Starch and sucrose metabolism 💬 | 1件: 298 298 |
9 |
Acetylcysteine
| 1件: Acetylcysteine Acetylcysteine | 3件: Acetylcysteine Acetylcysteine; Mucomyst; N-acetylcysteine; | - | - | 21件: 6 6, 13, 19, 20, 21, 49, 51, 53, 58, 63, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337 |
10 |
Diazepam
| 1件: Diazepam Diazepam | 1件: Diazepam Diazepam; | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 3件: 46 46, 155, 298 |
11 |
Dronabinol
| 1件: Dronabinol Dronabinol | 4件: Delta-9-tetrahydrocannabinol Delta-9-tetrahydrocannabinol; DRONABINOL; Sativex; Tetrahydrocannabinol; | 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 8件: 2 2, 8, 13, 36, 46, 96, 271, 298 |
12 |
Gabapentin
| 1件: Gabapentin Gabapentin | 4件: Gabapentin Gabapentin; GABAPENTINA; Gabapentine; NEURONTIN; | 5件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | 5件: 6 6, 13, 19, 70, 298 |
13 |
Triamcinolone
| 1件: Triamcinolone Triamcinolone | 4件: Kenalog Kenalog; Naltrexone; Triamcinolone; Triamcinolone Acetonide; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 11件: 35 35, 46, 53, 56, 70, 90, 96, 107, 162, 226, 298 |
14 |
Simvastatin
| 1件: Simvastatin Simvastatin | 3件: Simvastatin Simvastatin; Simvastatina; Simvastatine; | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 21件: 6 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 |
15 |
Omeprazole
| 1件: Omeprazole Omeprazole | 4件: Losec Losec; Omeprazol; Omeprazole; OMEPRAZOLE MAGNESIUM; | 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 14件: 6 6, 8, 21, 46, 51, 85, 96, 97, 225, 271, 282, 294, 298, 299 |
16 |
Pentoxifylline
| 1件: Pentoxifylline Pentoxifylline | 1件: Pentoxifylline Pentoxifylline; | - | - | 12件: 26 26, 56, 84, 86, 93, 96, 97, 113, 220, 222, 296, 298 |
17 |
Midazolam
| 1件: Midazolam Midazolam | 2件: Midazolam Midazolam; Midazolam injection; | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 |
18 |
Thalidomide
| 1件: Thalidomide Thalidomide | 1件: Thalidomide Thalidomide; | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 20件: 2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 |
19 |
Paricalcitol
| 1件: Paricalcitol Paricalcitol | 1件: Paricalcitol Paricalcitol; | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 5件: 19 19, 66, 218, 238, 298 |
20 |
Bentiromide
| 1件: Bentiromide Bentiromide | 0件: | - | - | 3件: 51 51, 117, 298 |
21 |
Proglumide
| 1件: Proglumide Proglumide | 1件: Proglumide Proglumide; | 1件: CCKBR CCKBR 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬 | 1件: 298 298 |
22 |
Magnesium L-aspartate
| 1件: Magnesium aspartate Magnesium aspartate | 1件: Magnesium aspartate Magnesium aspartate; | - | - | 1件: 298 298 |
23 |
Levocarnitine
| 1件: Levocarnitine Levocarnitine | 4件: Carnitine Carnitine; L-Carnitine; Levocarnitine; Xyzal; | - | - | 11件: 3 3, 5, 13, 53, 58, 86, 96, 97, 265, 298, 316 |
24 |
Tocopherol
| 1件: Tocopherol Tocopherol | 2件: Tocoferol Tocoferol; Tocopherol; | - | - | 6件: 13 13, 49, 90, 206, 257, 298 |
25 |
Pregabalin
| 1件: Pregabalin Pregabalin | 2件: Lyrica Lyrica; Pregabalin; | 4件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 | 7件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬 | 5件: 13 13, 36, 46, 70, 298 |
26 |
Oxycodone
| 1件: Oxycodone Oxycodone | 2件: OXYCODONE OXYCODONE; OXYCODONE HYDROCHLORIDE; | 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 6 6, 13, 70, 226, 298 |
27 |
Pancrelipase
| 1件: Pancrelipase Pancrelipase | 2件: Pancreatin Pancreatin; Pancrelipase; | - | - | 2件: 298 298, 299 |
28 |
Perflubutane
| 1件: Perflubutane Perflubutane | 1件: Perflubutane Perflubutane; | - | - | 2件: 298 298, 300 |
29 |
Ethanol
| 1件: Ethanol Ethanol | 3件: Alcohol Alcohol; Ethanol; PREDNISONE; | - | - | 5件: 58 58, 97, 279, 280, 298 |
30 |
Lacosamide
| 1件: Lacosamide Lacosamide | 1件: Lacosamide Lacosamide; | 2件: SCN3A SCN3A, SCN9A 💬 | 1件: Taste transduction Taste transduction 💬 | 4件: 2 2, 46, 149, 298 |
31 |
Amlodipine
| 1件: Amlodipine Amlodipine | 1件: Amlodipine Amlodipine; | 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 13 13, 51, 67, 298 |
32 |
Bupivacaine
| 1件: Bupivacaine Bupivacaine | 2件: Bupivacaine Bupivacaine; BUPIVACAINE HYDROCHLORIDE; | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 8件: 46 46, 51, 53, 70, 96, 168, 226, 298 |
33 |
Esomeprazole
| 1件: Esomeprazole Esomeprazole | 3件: Esomeprazole Esomeprazole; Nexium; Omeprazole; | 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 8件: 13 13, 46, 86, 98, 107, 113, 298, 299 |
34 |
Hydroxychloroquine
| 1件: Hydroxychloroquine Hydroxychloroquine | 3件: HYDROXYCHLOROQUINE HYDROXYCHLOROQUINE; HYDROXYCHLOROQUINE SULFATE; Plaquenil; | - | - | 27件: 13 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 |
35 |
Pioglitazone
| 1件: Pioglitazone Pioglitazone | 1件: Pioglitazone Pioglitazone; | 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 17件: 2 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
36 |
Sulfanilamide
| 1件: Sulfanilamide Sulfanilamide | 0件: | - | - | 4件: 6 6, 30, 60, 298 |
37 |
Reparixin
| 1件: Reparixin Reparixin | 1件: Reparixin Reparixin; | 2件: CXCR1 CXCR1, CXCR2 💬 | 7件: Chemokine signaling pathway Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, Human cytomegalovirus infection, Phospholipase D signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬 | 2件: 298 298, 299 |
38 |
Tanezumab
| 1件: Tanezumab Tanezumab | 1件: Tanezumab Tanezumab; | 1件: NGF NGF 💬 | 9件: Apoptosis Apoptosis, Calcium signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 2件: 226 226, 298 |